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1. INTRODUCTION {#joa312179-sec-0005}
===============

Pacemaker implantation is a common procedure performed as a first line therapy for patients with symptomatic bradycardia.[1](#joa312179-bib-0001){ref-type="ref"}, [2](#joa312179-bib-0002){ref-type="ref"} Most pacemakers are implanted below the collarbone and the leads are inserted through the subclavian vein.[3](#joa312179-bib-0003){ref-type="ref"} The main complications associated with lead implantation are cardiac perforation, lead dislodgement, and lead malfunction.[4](#joa312179-bib-0004){ref-type="ref"}, [5](#joa312179-bib-0005){ref-type="ref"} Currently, there are two main methods to deliver the pacing lead from the subclavian vein to the right ventricle. One is the stylet delivery system (SDS) and the other is the catheter delivery system (CDS). SDS requires experience in shaping the stylet and manipulating the lead through the tricuspid annulus to deliver the lead to the right ventricle.[6](#joa312179-bib-0006){ref-type="ref"} CDS is a relatively new technique introduced in 2012. The delivery method is completely different from SDS as the lead is delivered to the right ventricle through a catheter that is available with multiple preshaped features according to the location in which the lead should be positioned. The physician does not have to shape the stylet, and the catheter can be introduced into the right ventricle over the wire. Moreover, some of these catheters always point to the interventricular septum, which may help avoid cardiac perforation. With regard to these characteristics, CDS may improve the implantation procedure, especially for trainees, without increasing the risk of procedure‐related complications. However, no randomized controlled trial has previously addressed the question regarding the optimal lead implantation technique, especially when the implantation is being performed by trainees in the early stage of training. Therefore, this study aims to investigate and compare the two techniques of lead delivery by trainees in patients who are scheduled to undergo pacemaker implantation.

2. METHODS {#joa312179-sec-0006}
==========

2.1. Ethics and registration {#joa312179-sec-0007}
----------------------------

This is a multicenter, randomized controlled prospective study (UMIN Clinical Trials Registry UMIN000031849). All equipment was set up with no sponsor support. The study protocol was approved by the institutional review board (Ethics Committee) at National Cerebral and Cardiovascular Center, Japan. The study has been conducted in compliance with the Declaration of Helsinki.[7](#joa312179-bib-0007){ref-type="ref"} Informed consent will be obtained from the patients and/or their legal guardians.

2.2. Physician characteristics and patient inclusion and exclusion criteria {#joa312179-sec-0008}
---------------------------------------------------------------------------

The physicians performing the procedure were all trainees at the National Cerebral and Cardiovascular Center, Japan. They had previously performed less than five pacemaker implant operations as first operator but were appropriately trained to qualify for this study by assisting in implantations. The flow diagram is shown in Figure [1](#joa312179-fig-0001){ref-type="fig"}.

![Flow diagram of the study](JOA3-35-524-g001){#joa312179-fig-0001}

Patients aged 20‐90 years with an indication for a bradycardia pacemaker requiring a right ventricle lead will be considered eligible for the study. Patients with a known vascular access problem or a previously implanted medical device at the implantation site will be excluded.

2.3. Surgical procedure {#joa312179-sec-0009}
-----------------------

The pacemaker system available for CDS is manufactured by Medtronic (Select Secure system; Minneapolis, MN) and those for SDS are manufactured by Abbott (St. Paul, MN), Boston Scientific (Marlborough, MA), Biotronik (Berlin, Germany), and Sorin (Clamart, France). The pacemaker pocket formation and vascular access operations will be performed based on the preference of the operator, who is assigned to the patients randomly. After successful lead implantation, the pocket closure will also be performed by the trainee operator. The entire procedure will be supervised by an expert cardiologist, with experience of more than 100 pacemaker implantations.

2.4. Randomization {#joa312179-sec-0010}
------------------

The patients will be randomized at a 1:1 ratio to either the CDS group or the SDS group. Randomization is performed using an in‐house validated mail‐based system, based on a minimization scheme with stratification by the operator. The patients' group allocations will be revealed to the surgeon at least 1 day before the operation.

The study was designed to enroll 100 patients, which produces a two‐sided 95% confidence interval for the between‐group difference in the number of attempts needed to place the lead, with a distance from the difference in means to the limits that is equal to 0.198, 0.397, and 0.794 when the estimated standard deviations are 0.5, 1.0, and 2.0, respectively.

2.5. Data collection {#joa312179-sec-0011}
--------------------

The patient characteristics at enrollment, periprocedural variables, and outcome variables at follow‐up that will be analyzed are presented in Table [1](#joa312179-tbl-0001){ref-type="table"}. To record the intraprocedural parameters, recording will start when the lead is inserted into the sheath and end when a sensing threshold \>5.0 mV and pacing threshold \<1.0 V at 0.5 ms is achieved, or when the supervising cardiologist determines that the trainee cannot accomplish the procedure safely. The primary endpoint is the total number of attempts needed to place the lead in the ideal position. For safety considerations, the incidence of lead perforation, lead dislodgement after implantation, and other complications requiring intervention will be recorded.

###### 

Patient baseline characteristics and parameters measured in the study

  ---------------------------------------------------------
  Patient characteristics
  Age, years
  Male sex, n (%)
  Body height, cm
  Body weight, kg
  12‐lead electrocardiograms
  Heart rate
  QRS duration
  Chest x‐ray
  Lead position
  Other abnormal findings, n (%)
  Indication for pacemaker implantation
  Sick sinus syndrome
  Atrial fibrillation with bradycardia
  Complete atrioventricular block
  Advanced atrioventricular block
  Lead parameters
  Pacing threshold
  Sensing threshold
  Intraprocedural parameters
  Fluoroscopy time (min)
  Fluoroscopy (dosage)
  Lead delivery time (min)
  Need for changing physician (yes/no)
  Number of attempts to achieve ideal lead parameters (n)
  Complication requiring medical intervention
  ---------------------------------------------------------
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Patients will be evaluated at the pacemaker outpatient clinic within 14 days of the procedure and again at 1 month.

2.6. Monitoring {#joa312179-sec-0012}
---------------

At each visit after the operation, the principal investigator or other investigators will interview the patient. When an adverse event occurs, the principal investigator or investigator will follow the patient until the adverse event is resolved and will enter the data into the website.

The data monitoring committee, which is independent of the investigators, will perform the central monitoring of the data stored on the website.

2.7. Data quality control and management {#joa312179-sec-0013}
----------------------------------------

The primary investigator or other investigators must follow the instructions of this study protocol. They cannot modify the protocol without permission from the ethics committee and must record any deviation from it.

When any new data are identified that requires revision of the protocol, and the data monitoring committee recommends revision, the representative investigator of the trial will revise the protocol. The revision of the protocol must be approved by the ethics committee.

2.8. Statistical analysis {#joa312179-sec-0014}
-------------------------

The intention‐to‐treat analyses will be performed in both the total population of all participating cardiologists, and in the separate subgroups of expert operators, and trainees.

Continuous variables will be presented as mean ± standard deviation, median with interquartile range (25th‐75th percentiles), or range (minimum and maximum) and compared using either a two‐sided *t* test or the Mann‐Whitney U test for independent samples, as appropriate. Fisher\'s exact test will be used for analyzing categorical variables. A *P *\< 0.05 is considered significant. All analyses will be performed using the SPSS 17.0 statistical package (SPSS, Inc., Chicago, IL).

3. RESULTS {#joa312179-sec-0015}
==========

The results of this study are currently under investigation.

4. DISCUSSION {#joa312179-sec-0016}
=============

Implantation of a permanent pacemaker is a common procedure performed by both trainees and cardiology specialists. Patients requiring pacemaker implantation are geriatric with comorbid conditions.[8](#joa312179-bib-0008){ref-type="ref"} Thus, a safe and efficient technique is required. SDS has been the only method for lead delivery for more than 20 years and is currently the standard technique for lead implantation. Currently, CDS is reported to be an important delivery system when performing His‐pacing and implanting leads in patients with congenital heart disease.[9](#joa312179-bib-0009){ref-type="ref"}, [10](#joa312179-bib-0010){ref-type="ref"} In this study, we will compare SDS and CDS to test our hypothesis that the catheter‐based delivery system is a safer and significantly more efficient technique than SDS, as the specific catheter always points to the interventricular septum. Thus, CDS does not need special training as is needed for shaping the stylet and manipulating the lead to cross the tricuspid annulus in SDS. The number of pacemaker implantations required is growing worldwide and this study may help determine the optimal technique for lead delivery and result in improved pacemaker surgery.

5. CONCLUSIONS {#joa312179-sec-0017}
==============

The CATS delivery system trial will be the first prospective investigation assessing and comparing the clinical benefit and safety of the CDS and SDS techniques in pacemaker implantation. These findings may provide guidance, especially to trainees, in deciding on the optimal surgical technique to use for patients undergoing pacemaker implantations.
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